{
    "2018-04-27": [
        [
            {
                "time": "2018-05-01",
                "original_text": "Biotech Stocks Facing FDA Decision In May",
                "features": {
                    "keywords": [
                        "FDA",
                        "decision",
                        "biotech"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-26",
                "original_text": "How Vertex Pharmaceuticals’ Drugs Performed in 1Q18",
                "features": {
                    "keywords": [
                        "Vertex",
                        "drugs",
                        "performance"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-25",
                "original_text": "GlaxoSmithKline’s 1Q18 Earnings: Revenue Trend",
                "features": {
                    "keywords": [
                        "GlaxoSmithKline",
                        "earnings",
                        "revenue"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-27",
                "original_text": "How Did BioMarin Pharmaceutical Perform in 1Q18?",
                "features": {
                    "keywords": [
                        "BioMarin",
                        "performance",
                        "earnings"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-24",
                "original_text": "Roche (RHHBY) Q1 Earnings: Ocrevus, Perjeta Drive Sales Beat",
                "features": {
                    "keywords": [
                        "Roche",
                        "earnings",
                        "sales beat"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-23",
                "original_text": "What's in the Cards for Conatus (CNAT) This Earnings Season?",
                "features": {
                    "keywords": [
                        "Conatus",
                        "earnings season"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-20",
                "original_text": "Greek parliament cannot investigate Novartis case, committee says",
                "features": {
                    "keywords": [
                        "Novartis",
                        "investigation",
                        "parliament"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-27",
                "original_text": "Can Jafaki Help Incyte (INCY) Beat Earnings Estimates in Q1?",
                "features": {
                    "keywords": [
                        "Jafaki",
                        "Incyte",
                        "earnings estimates"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-26",
                "original_text": "The Swiss Stock Market Finished Little Changed In Choppy Trade",
                "features": {
                    "keywords": [
                        "Swiss stock market",
                        "choppy trade"
                    ],
                    "sentiment_score": 0.1,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}